𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon alfa-2a in recurrent metastatic hemangiopericytoma

✍ Scribed by Lackner, Herwig ;Urban, Christian ;Dornbusch, Hans J�rgen ;Schwinger, Wolfgang ;Kerbl, Reinhold ;Sovinz, Petra


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
141 KB
Volume
40
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Further experience with recombinant inte
✍ S. D. Fosså; S. T. De Garis 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 404 KB

Thirty-three patients with measurable metastatic renal cell carcinoma were entered into 2 consecutive phase II protocols using interferon alfa-2a. In protocol I, 20 patients were treated with interferon alfa-2a at a dose of 36 x I06 IU i.m. t.i.w. Vinblastine was also given t o 18 of these patients

Treatment of metastatic malignant melano
✍ T. Dorval; T. Palangie; M. Jouve; E. Garcia-Giralt; E. Falcoff; D. Schwab; M. Le 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 151 KB

Twenty-six patients with histologically proven metastatic malignant melanoma were included in a phase II trial of interferon alfa-2b (Intron A; Schering-Plough). Patients were given 10 X 10(6) IU/m2 of interferon alfa-2b subcutaneously three times a week until major intolerance or progression of dis

Clinical studies of recombinant interfer
✍ Tetsuo Taguchi 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views

A Phase I study of interferon alfa-2a was conducted in 20 patients with disseminated cancer to establish the relationship between dose and interferon-related side effects. Fever was the most common side effect, and was not doserelated. Other side effects not related to dose included flu-like symptom